6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: ASCENTAGE PHARMA GROUP INTERNATIONAL
Filed: April 24, 2025
Period of Report: April 24, 2025
Accession Number: 0001213900-25-034806

View Document ↗ View on SEC.gov ↗